Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA's 'Great' Generic Approval Engine Can Be Better, New OGD Director Says

Apr 02 2019

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Let's Get Real – ANDA Approval Likely Takes More Than Two Years, US FDA Says

Apr 15 2018

US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating

Oct 12 2018

US FDA Again Looks Outside Generic Drugs Office For New Director

Feb 12 2019

Generic Industry Once Again Must Get To Know New US FDA Office Director

Feb 14 2019

CREATES Act Has a Penalty Problem

Mar 28 2019

Generic Advair's Labeling Variation Stems From Permissible Design Differences, US FDA Says

Feb 11 2019

Lack Of Priority? No ANDAs Approved Using Expedited Pathway In FY 2018

Nov 05 2018

Related Companies

GSK plc

Viatris Inc.

Parexel International Corp.

Additional Topics

United States FDA Generic Drugs Regulation Leadership BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window